Last updated on November 2017

A Randomized, Double-blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of Herpes Simplex Virus, Type 2 (HSV-2) Therapeutic DNA Vaccine in Adults with Symptomatic Genital HSV-2 Infection.


Brief description of study

A Randomized, Double-blind, Placebo-Controlled, Phase 2 Trial to Evaluate the Safety and Efficacy of Herpes Simplex Virus, Type 2 (HSV-2) Therapeutic DNA Vaccine in Adults with Symptomatic Genital HSV-2 Infection.

Detailed Study Description

The purpose of this study is to evaluate the safety and effectiveness of an investigational vaccine for Herpes Simplex Virus Type II as compared to a placebo vaccine.

Clinical Study Identifier: TX14827

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Central Kentucky Research Associates

Central Kentucky Research Associates
Lexington, KY USA
  Connect »